Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.48 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15916220 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL1162359 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL145000 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL5043328 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL2065907 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL147622 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL3363663 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| Bromide SCHEMBL9771320 | 0.98 | KDM4E (0.54) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| Hydrochloric Acid SCHEMBL9779186 | 0.98 | ALDH1A1 (0.57) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| Benzoic Acid SCHEMBL6048463 | 0.87 | DAO (0.48) | KDM4EADRA2AADRA2CLMNAHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 779 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025108372-A1 | TEMPERATURE-RESISTANT POLYMER AND PREPARATION METHOD THEREFOR, AND USE OF CYCLIC IMIDE DIOL COMPOUND | 元素驱动(杭州)生物科技有限公司 | 2025-05-30 | — | — | WO | claimed |
| WO-2025108371-A1 | COPOLYMER WITH IMPROVED STRENGTH AND PREPARATION METHOD THEREFOR | 元素驱动(杭州)生物科技有限公司 | 2025-05-30 | — | — | WO | claimed |
| CN-113330004-B | Differential solubility driven asymmetric conversion process for substituted 2H-chromene-3-carboxylic acids | 株式会社AskAt | 2023-11-17 | — | — | CN | claimed |
| EP-3906232-B1 | PROCESS FOR THE DIFFERENTIAL SOLUBILITY-DRIVEN ASYMMETRIC TRANSFORMATION OF SUBSTITUTED 2H-CHROMENE-3-CARBOXYLIC ACIDS | ASKAT INC (JP) | 2023-05-10 | — | — | EP | claimed |
| CN-109180843-B | Non-phthalate compounds as electron donors for polyolefin catalysts | 美国台塑公司 | 2022-03-01 | — | — | CN | claimed |
| CN-110407964-B | Catalyst component for olefin polymerization and preparation method thereof | 中国石油化工股份有限公司 | 2021-09-21 | — | — | CN | claimed |
| CN-110407963-B | Catalyst component for olefin polymerization and preparation method thereof | 中国石油化工股份有限公司 | 2021-09-21 | — | — | CN | claimed |
| CN-110437435-B | One-step synthesis method of terminal amino-functionalized polyether | 华南理工大学 | 2021-08-10 | — | — | CN | claimed |
| US-11065238-B2 | Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases | ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) (FR) | 2021-07-20 | — | — | US | claimed |
| EP-2938594-B1 | METHOD FOR THE SYNTHESIS OF ALPHA/ALPHA-PRIME-ALCOXYLATED GLYCEROL LINEAR CARBONIC ESTERS | CHRYSO (FR) | 2020-06-17 | — | — | EP | claimed |
| EP-0130633-B1 | Process for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives | ZAMBON SPA (IT) | 1996-10-09 | — | — | EP | claimed |
| EP-0678506-A2 | Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives | ZAMBON GROUP S.p.A. (IT) | 1995-10-25 | — | — | EP | claimed |
| EP-0677511-A2 | Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives | ZAMBON GROUP S.p.A. (IT) | 1995-10-18 | — | — | EP | claimed |
| EP-0423705-B1 | Process for the stereochemical inversion of (2S,3S)-2-amino-3-phenyl-1,3-propanediols into their (2R,3R) enantiomers | ZAMBON SPA (IT) | 1995-01-11 | — | — | EP | claimed |
| US-5367094-A | Hydrogenation for dehydroxylation of 2-amino-1-phenyl-1,3-propanediol in the presence of strong acid | YUKONG, LTD. (KR) | 1994-11-22 | — | — | US | claimed |
| EP-0423705-A2 | Process for the stereochemical inversion of (2S,3S)-2-amino-3-phenyl-1,3-propanediols into their (2R,3R) enantiomers | ZAMBON GROUP S.p.A. (IT) | 1991-04-24 | — | — | EP | claimed |
| US-4814477-A | SALT FORMATION, CRYSTALLIZATION, HYDROLYSIS | OCE-NEDERLAND B.V. (NL) | 1989-03-21 | — | — | US | claimed |
| EP-0085023-A1 | Process for the separation of enantiomers by partition between liquid phases | CIBA-GEIGY AG (CH) | 1983-08-03 | — | — | EP | claimed |
| US-4335057-A | 4-(2',2,2'-Trihalogenoethyl)-cyclobutane-1-sulfonic acid salts with optically active bases | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | claimed |
| US-4299967-A | Process for producing optically active 2-(2,2-dihalogenovinyl)-cyclopropane-1-carboxylic acids substituted in the 3-position, and derivatives thereof, as well as novel 4-(2,2,2-trihalogenoethyl)-cyclobutane-1-sulfonic acid salts | CIBA-GEIGY CORPORATION (US) | 1981-11-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11065238-B2 | Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases | GBA1, SMN1; SMN2, GAA | KDM4E 3898/4885ADRA2A 4123/4885ADRA2C 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.